Aldose Reductase Inhibitors for Diabetic Cataract: A Study of Disclosure Patterns in Patents and Peer Review Papers

Journal Title: Ophthalmology Research: An International Journal - Year 2014, Vol 2, Issue 3

Abstract

Aims: To investigate, for 13 aldose reductase inhibitors that had been in development for diabetic cataract, whether patent documents could provide earlier dissemination of knowledge to the ophthalmology community than peer review papers. Methodology: Searches for intellectual property disclosures were conducted in our internal database of ophthalmology patent documents, and were supplemented by online searches in the public Espacenet and Google Patents databases. Searches for peer review papers were performed in Pub Med and Google Scholar, and in our internal database of machine-readable ophthalmology publications. Results: For sorbinil, tolrestat, fidarestat and GP-1447 patent documents clearly preempted the peer review literature in terms of data-supported information on potential effectiveness in diabetic cataract, typically by 7-17 months. For alrestatin, zenarestat, zopolrestat, indomethacin, and quercitrin academic journals were clearly first to properly report this therapeutic utility, preempting the corresponding patents by 6 months to several years. For ponalrestat, risarestat, epalrestat, and lidorestat claims of utility in diabetic cataract were first made in patent documents, but with insufficient or incomplete support. Conclusion: Our results suggest that including patent documents in the routine monitoring of newly disclosed knowledge could significantly improve the comprehensiveness of the literature base in ocular pharmacology, and has the potential to alert researchers to emerging drug candidates earlier than reports in the peer review literature.

Authors and Affiliations

H. A. M. Mucke, E. Mucke, P. M. Mucke

Keywords

Related Articles

Peculiar Case of Orbital Emphysema Caused by High-pressure Water Jet

Aim: To report an unusual case of orbital emphysema secondary to high pressure water jet injury. Presentation of Case: A 26-year-old Indian male sustained a two-centimeter facial laceration after a compressed water jet h...

Bilateral Endogenous Endophthalmitis as an Initial Presentation of Klebsiella pneumoniae Bacteremia in Advanced Hepatocellular Carcinoma

Aims: To report a case of Klebsiella pneumoniae bacteremia presenting as bilateral endogenous endophthalmitis in a patient with advanced hepatocellular carcinoma and liver failure. Presentation of Case: We describe a 55...

Multimodal Views of the Human Retina

Aims:To show the relationships among subject-reported measures of vision, the view through an ophthalmoscope, the view through a slit lamp, the view through a clinician’s eye, optical coherence tomography (OCT) images, f...

Intraoperative Complications of Laser in Situ Keratomileusis in Yazd

Purpose: Laser in situ keratomileusis (LASIK) is a popular method for correcting refractive errors. We survived the incidence and types of LASIK intraoperative flap complications in Yazd refractive surgery center. Method...

Serratia marcescens Lacrimal Canaliculitis

Introduction: Serratia marcescens is a motile, facultatively anaerobic gram-negative rod of the Enterobacteriaceae family and has been implicated mostly in contact lens related keratitis. We report a case of lacrimal duc...

Download PDF file
  • EP ID EP338952
  • DOI 10.9734/OR/2014/7224
  • Views 120
  • Downloads 0

How To Cite

H. A. M. Mucke, E. Mucke, P. M. Mucke (2014). Aldose Reductase Inhibitors for Diabetic Cataract: A Study of Disclosure Patterns in Patents and Peer Review Papers. Ophthalmology Research: An International Journal, 2(3), 137-149. https://www.europub.co.uk/articles/-A-338952